MRI inflammation of the hand interosseous tendons occurs in anti-CCP-positive at-risk individuals and may precede the development of clinical synovitis.


Journal

Annals of the rheumatic diseases
ISSN: 1468-2060
Titre abrégé: Ann Rheum Dis
Pays: England
ID NLM: 0372355

Informations de publication

Date de publication:
06 2019
Historique:
received: 23 08 2018
revised: 01 02 2019
accepted: 04 03 2019
pubmed: 25 3 2019
medline: 30 1 2020
entrez: 25 3 2019
Statut: ppublish

Résumé

Interosseous tendon inflammation (ITI) has been described in rheumatoid arthritis (RA). Whether ITI occurs in at-risk individuals before the onset of clinical synovitis is unknown. To investigate, by MRI, ITI in anti-cyclic citrullinated peptide (CCP)-positive at-risk individuals (CCP +at risk) and to describe the anatomy, prevalence and clinical associations across the RA continuum. Hand MRI was performed in 93 CCP + at risk, 47 early RA (ERA), 28 established 'late' RA (LRA) and 20 healthy controls (HC) and scored for ITI, flexor tenosynovitis (TSV) and RA MRI scoring at the metacarpophalangeal joints (MCPJs). Cadaveric and histological studies were performed to explore the anatomical basis for MRI ITI. The proportion of subjects with ITI and the number of inflamed interosseous tendons (ITs) increased along the disease continuum (p<0.001): 19% of CCP +at risk, 49% of ERA and 57% of LRA had ≥1 IT inflamed . ITI was not found in any HC. ITI was more frequently identified in tender MCPJs compared with nontender MCPJs (28% vs 12%, respectively). No IT tenosynovial sheath was identified in cadavers on dissection or histological studies suggesting MRI findings represent peritendonitis. Dye studies indicated no communication between the IT and the joint. ITI occurs in CCP + at-risk individuals and can precede the onset of clinical synovitis. The ITs may be important nonsynovial extracapsular targets in the development and progression of RA.

Identifiants

pubmed: 30904831
pii: annrheumdis-2018-214331
doi: 10.1136/annrheumdis-2018-214331
doi:

Substances chimiques

Anti-Citrullinated Protein Antibodies 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

781-786

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Kulveer Mankia (K)

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
NIHR Leeds Biomedical Research Centre, Leeds, UK.

Maria-Antonietta D'Agostino (MA)

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
Department of Rheumatology, Ambroise Paré Hospital, APHP, Université Versailles-Saint-Quentin en Yvelines, Boulogne-Billancourt, France.

Emma Rowbotham (E)

NIHR Leeds Biomedical Research Centre, Leeds, UK.
Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Elizabeth Ma Hensor (EM)

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.

Laura Hunt (L)

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
NIHR Leeds Biomedical Research Centre, Leeds, UK.

Ingrid Möller (I)

Instituto Poal de Reumatología, University of Barcelona, Barcelona, Spain.

Misabel Miguel (M)

Anatomy Department, Universitat de Barcelona, Barcelona, Spain.

José Ramon Mérida-Velasco (JR)

Department of Anatomy and Emryology, Universidad Complutense de Madrid, Madrid, Spain.

Jorge Murillo-González (J)

Department of Anatomy and Emryology, Universidad Complutense de Madrid, Madrid, Spain.

Esperanza Naredo (E)

Department of Rheumatology, Bone and Joint Research Unit, Universidad Autonoma de Madrid, Madrid, Spain.

Jacqueline Leong Nam (JL)

NIHR Leeds Biomedical Research Centre, Leeds, UK.

Ai Lyn Tan (AL)

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK.
NIHR Leeds Biomedical Research Centre, Leeds, UK.

Jane E Freeston (JE)

NIHR Leeds Biomedical Research Centre, Leeds, UK.

Andrew Grainger (A)

NIHR Leeds Biomedical Research Centre, Leeds, UK.
Department of Radiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.

Paul Emery (P)

Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, UK p.emery@leeds.ac.uk.
NIHR Leeds Biomedical Research Centre, Leeds, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH